Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - CAPITAL EXPENDITURES
Capital Expenditures NBIX - Neurocrine Biosciences, Inc.
-38.2 M
LAST VALUE
-52.16%
2 YEAR CAGR
-20.97%
5 YEAR CAGR
-37.24%
10 YEAR CAGR